Skip to main content
Company Announces Regulatory Filing for Nemolizumab for Two Indications
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Company Announces Regulatory Filing for Nemolizumab for Two Indications
User login
Username
Password
Reset your password
Concept
Lead
score
Biologic Therapy
1
1
Prurigo Nodularis
0
0.69
Dermatitis
0
0.62
Atopic Dermatitis
0
0.34
Calcaneal
0
0.34
Pruritus
0
0.34
Healthcare and Medical Technology
0
0.18
Adolescent Medicine
0
0.17
Clinical Research
0
0.17
Europe
0
0.17
Food and Drug Administration (FDA)
0
0.17
Grant
0
0.17
Interleukin
0
0.17
Monoclonal Antibody
0
0.17
Skin Lesion
0
0.17
Specialty
Lead
score
Dermatology
1
1
Family Medicine/Primary Care
0
0.94
Allergy & Clinical Immunology
0
0.52
Internal Medicine
0
0.49
Pediatrics
0
0.44
Pharmacist
0
0.36
Edit Tags